Cabot Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-161,656
Closed -$1.98M 134
2017
Q3
$1.98M Buy
161,656
+65,552
+68% +$1.16M 0.44% 63
2017
Q2
$1.76M Buy
96,104
+5,264
+6% +$97.2K 0.41% 68
2017
Q1
$1.92M Sell
90,840
-2,112
-2% -$41.2K 0.47% 67
2016
Q4
$1.39M Sell
92,952
-12,196
-12% -$216K 0.38% 77
2016
Q3
$2.3M Sell
105,148
-86,392
-45% -$1.92M 0.59% 63
2016
Q2
$3.8M Sell
191,540
-3,700
-2% -$63K 1% 37
2016
Q1
$3.31M Sell
195,240
-2,588
-1% -$43.2K 0.92% 44
2015
Q4
$4.05M Buy
197,828
+1,944
+1% +$40.5K 1.04% 36
2015
Q3
$4.21M Sell
195,884
-87,896
-31% -$1.96M 1.16% 30
2015
Q2
$5.67M Sell
283,780
-101,340
-26% -$1.78M 1.38% 17
2015
Q1
$6M Sell
385,120
-1,716
-0.4% -$25.9K 1.46% 16
2014
Q4
$5.32M Sell
386,836
-52,264
-12% -$640K 1.31% 22
2014
Q3
$4.39M Sell
439,100
-3,376
-0.8% -$34.5K 1.12% 34
2014
Q2
$4.39M Buy
442,476
+185,868
+72% +$1.65M 1.1% 34
2014
Q1
$2.65M Sell
256,608
-97,760
-28% -$1.01M 0.7% 67
2013
Q4
$3.14M Buy
354,368
+408
+0.1% +$3.23K 0.82% 58
2013
Q3
$2.5M Buy
+353,960
New +$2.24M 0.75% 67

Other funds holding DXCM

Cabot Wealth Management's DXCM Position: Q4 2017 in Review

Cabot Wealth Management sold out of DexCom (DXCM) in Q4 2017, closing a stake of 161,656 shares — an estimated $1.98M sold.

Cabot Wealth Management first reported a position in DXCM in Q3 2013 and held it in 17 quarters. The position peaked at $6M in Q1 2015. 273 funds tracked by Wall St. Rank hold DXCM as of Q4 2017.

  • Cabot Wealth Management reported no remaining DexCom position as of Q4 2017 after selling out during the quarter.
  • Cabot Wealth Management sold 161,656 DexCom shares in Q4 2017, an estimated $1.98M.
  • Cabot Wealth Management first reported a position in DexCom in Q3 2013 and held it in 17 quarters.
  • Cabot Wealth Management's DexCom position peaked at $6M in Q1 2015.
  • 273 funds tracked by Wall St. Rank held DexCom as of Q4 2017.

Based on Cabot Wealth Management's 13F filing for Q4 2017, filed 12 Feb 2018.